| Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells BG Till, MC Jensen, J Wang, EY Chen, BL Wood, HA Greisman, X Qian, ... Blood, The Journal of the American Society of Hematology 112 (6), 2261-2271, 2008 | 906 | 2008 |
| Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains J Wang, M Jensen, Y Lin, X Sui, E Chen, CG Lindgren, B Till, ... Human gene therapy 18 (8), 712-725, 2007 | 332 | 2007 |
| Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membrane SE James, PD Greenberg, MC Jensen, Y Lin, J Wang, BG Till, ... The Journal of Immunology 180 (10), 7028-7038, 2008 | 318 | 2008 |
| Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity A Ghosh, M Smith, SE James, ML Davila, E Velardi, KV Argyropoulos, ... Nature medicine 23 (2), 242-249, 2017 | 240 | 2017 |
| Posttransplant chimeric antigen receptor therapy M Smith, J Zakrzewski, S James, M Sadelain Blood, The Journal of the American Society of Hematology 131 (10), 1045-1052, 2018 | 96 | 2018 |
| Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in … SE James, NN Orgun, TF Tedder, MJ Shlomchik, MC Jensen, Y Lin, ... Blood, The Journal of the American Society of Hematology 114 (27), 5454-5463, 2009 | 64 | 2009 |
| Mathematical modeling of chimeric TCR triggering predicts the magnitude of target lysis and its impairment by TCR downmodulation SE James, PD Greenberg, MC Jensen, Y Lin, J Wang, LE Budde, BG Till, ... The Journal of immunology 184 (8), 4284-4294, 2010 | 40 | 2010 |
| A therapeutic cancer vaccine delivers antigens and adjuvants to lymphoid tissues using genetically modified T cells JR Veatch, N Singhi, S Srivastava, JL Szeto, B Jesernig, SM Stull, ... The Journal of Clinical Investigation 131 (16), 2021 | 17 | 2021 |
| IL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse model BD Ng, A Rajagopalan, AI Kousa, JS Fischman, S Chen, A Massa, ... Blood 144 (2), 171-186, 2024 | 3 | 2024 |
| CCR1-Targeting CAR T Cells for Acute Myeloid Leukemia S Chen, AP Boardman, SE James, MRM van den Brink Blood 142, 4808, 2023 | 1 | 2023 |
| Leucine zipper-based sorting system enables generation of multi-functional CAR T cells SE James, S Chen, BD Ng, JS Fischman, L Jahn, AP Boardman, ... bioRxiv, 2023.09. 13.557232, 2023 | 1 | 2023 |
| Targeting CD47 in lymphoid malignancies with CAR T cells. AP Boardman, S James, MRM Van Den Brink Journal of Clinical Oncology 41 (16_suppl), 2513-2513, 2023 | 1 | 2023 |
| Murine donor 1928z CAR T cells exert potent graft-versus-lymphoma activity without graft-versus-host-disease M Smith, A Ghosh, S James, ML Davila, E Velardi, KV Argyropoulos, ... Blood 128 (22), 653, 2016 | 1 | 2016 |
| Correction: Mathematical Modeling of Chimeric TCR Triggering Predicts the Magnitude of Target Lysis and Its Impairment by TCR Downmodulation SE James, PD Greenberg, MC Jensen, Y Lin, J Wang, LE Budde, BG Till, ... The Journal of Immunology 185 (2), 1340-1340, 2010 | 1 | 2010 |
| Leucine zipper-based immunomagnetic purification of CAR T cells displaying multiple receptors SE James, S Chen, BD Ng, JS Fischman, L Jahn, AP Boardman, ... Nature Biomedical Engineering, 1-23, 2024 | | 2024 |
| Effector Differentiation and Exhaustion Attenuate on-Target, Off-Tumor Toxicity of CD24 CAR T Cells AP Boardman, A Rajagopalan, S Chen, B Ng, J Fischman, A Massa, ... Blood 144, 2030, 2024 | | 2024 |
| Dual-Vector-Transduction with Single-Step Magnetic Selection (Zip-sort) Increases Transgenic Payloads to Enhance CAR T Cell Activity SE James, S Chen, B Ng, J Fischman, L Jahn, AP Boardman, ... Blood 144, 501, 2024 | | 2024 |
| Regulatory T Cell Derived Trefoil Factor 1 Drives Thymic Regeneration in Allogeneic Hematopoietic Cell Transplantation J Pierce, B Gipson, L Serrano-Marin, KV Argyropoulos, S DeWolf, ... Blood 144, 2010, 2024 | | 2024 |
| Luteinizing hormone receptor binding agents and luteinizing hormone agonists to identify, expand, ablate and modify stem cells J Dudakov, M van den Brink, E Velardi, HP Kiem, S Radtke, S James US Patent App. 18/208,490, 2024 | | 2024 |
| Luteinizing hormone receptor binding agents and luteinizing hormone agonists to identify, expand, ablate and modify stem cells J Dudakov, M van den Brink, E Velardi, HP Kiem, S Radtke, S James US Patent 11,786,557, 2023 | | 2023 |